Valiant Laboratories Limited has informed the Exchange regarding Board meeting held on February 11, 2026 to Consider and approve audited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories has informed the stock exchange that its Board of Directors will meet on February 11, 2026. The agenda is to consider and approve the audited standalone and consolidated financial results for the quarter ending December 31, 2025, along with the nine-month period. No actual financial numbers or outcomes have been shared in this announcement. This is a standard advance notice required under listing rules before results are declared.
This is purely a procedural notice with no immediate impact on shareholders. Investors should watch for the actual results to be released after the board meeting to assess the company's performance.